Market Tracker

10/30 10:00pm ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

131.51
Data as of Oct 30
 +1.75 / +1.35%
Today’s Change
102.60
Today|||52-Week Range
153.10
+12.02%
Year-to-Date

Today’s Trading

Previous close129.76
Today’s open129.92
Day’s range129.27 - 134.00
Volume1,507,549
Average volume (3 months)2,779,746
Market cap$43.6B
Dividend yield--
Data as of 4:02pm ET, 10/30/2014

Growth & Valuation

Earnings growth (last year)-610.53%
Earnings growth (this year)+32.31%
Earnings growth (next 5 years)+33.90%
Revenue growth (last year)+62.68%
P/E ratio--
Price/Sales6.53
Price/Book8.44

Competitors

 Today’s
change
Today’s
% change
SHPGShire PLC+2.97+1.51%
ALXNAlexion Pharmaceutic...+2.44+1.28%
AGNAllergan Inc+2.67+1.43%
VRTXVertex Pharmaceutica...+0.94+0.86%
Data as of 4:07pm ET, 10/30/2014

Financials

Last reporting dateOctober 20, 2014
EPS forecast (this quarter)$2.11
Annual revenue (last year)$5.8B
Annual profit (last year)-$866.1M
Net profit margin-15.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts